Skip to main content
. 2022 Mar 19;14(6):1574. doi: 10.3390/cancers14061574

Table 4.

PFS and OS based on ctDNA and LB status.

PFS Baseline (n = 47)
ctDNA (+) ctDNA (−) p Liquid (+) Liquid (−) p
N/Events 29/27 18/14 38/35 9/6
Median 6.0 15.9 0.012
(Figure 1)
6.0 18.6 0.020
(Figure S3)
Min–Max 0.8–52.8 2.6–46.4 0.8–52.8 3.0–44.8
95% C.I. 3.8–8.3 8.6–23.3 3.8–8.2 15.0–22.2
Post-1 (n = 47)
ctDNA (+) ctDNA (−) p Liquid (+) Liquid (−) p
N/Events 13/13 34/28 23/22 24/19
Median 2.8 9.3 <0.001 3.3 8.2 0.056
Min–Max 0.8–5.9 2.6–52.8 0.8–52.8 2.6–44.8
95% C.I. 1.4–4.1 4.4–14.2 0.6–6.1 5.8–10.6
OS Baseline (n = 47)
ctDNA (+) ctDNA (−) p Liquid (+) Liquid (−) p
N/Events 29/26 18/9 38/30 9/5
Median 13.5 30.9 0.005
(Figure 2A)
14.9 25.9 0.093
Min–Max 2.1–52.8 4.3–48.9 2.1–52.8 6.5–44.8
95% C.I. 10.4–16.6 14.6–47.2 12.3–17.5 13.5–38.3
1-year OS 58.6% 88.9% 62.9% 100%
Post-1 (n = 47)
ctDNA (+) ctDNA (−) p Liquid (+) Liquid (−) p
N/Events 13/13 34/22 23/18 24/17
Median 4.7 22.0 <0.001
(Figure 2B)
14.3 20.2 0.269
Min–Max 2.1–15.2 4.3–52.8 2.1–52.8 4.3–48.9
95% C.I. 1.5–8.0 13.7–30.2 9.9–18.8 14.9–25.5
1-year OS 23.1% 88.1% 56.5% 83.1%
EOT (n = 39)
ctDNA (+) ctDNA (−) p Liquid (+) Liquid (−) p
N/Events 24/23 15/10 29/25 10/8
Median 6.0 12.0 0.003
(Figure 2C)
7.1 10.0 0.250
Min–Max 0–20.1 0.2–27.7 0–27.7 0.2–27.0
95% C.I. 0–12.6 9.2–14.8 1.3–12.9 0–20.8
1-year OS 17.5% 46.7% 25.1% 40.0%

p-values marked with bold indicate statistically significant.